• Home
  • >
  • Indoco Remedies Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/indoco-remedies-ltd.png Logo

Indoco Remedies Ltd Financial Statement

Indoco Remedies Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue469.27451.98474.51
Operating Expense388.13391.96400.97
Net Profit37.5620.0133.14
Net Profit Margin84.436.98
Earning Per Share4.082.173.6
EBIDTA82.6655.2574.16
Effective Tax Rate12.893.7315.65

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Indoco Remedies Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual1,668.611,540.751,241.53
Operating Expenses Annual1,382.521,213.411,017.26
Operating Profit Annual288.43329.67227.38
Interest Annual25.0314.1422.26
Depreciation54.4249.1349.17
Net Profit Annual142.25154.893.05
Tax Annual50.5481.7738.95

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Indoco Remedies Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning17.479.4223.76
Cash Flow from Operations178.84173.8382.22
Cash Flow from Investing-208.17-121.41-66.69
Cash Flow from Financing22.8-44.37-29.87
Cash Flow at the End10.9317.479.42

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Indoco Remedies Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)17.2921.418.31
PBIT Margin (%)13.0516.2712.42
PBT Margin (%)12.5315.1211.86
Net PROFIT Margin (%)8.4810.047.45
Return On Networth / Equity (%)14.7218.512.85
Return On Networth /Employed(%)16.7422.0815.06
Return On Assets (%)10.8613.659.01
Total Debt / Equity(X)0.310.310.36
Asset Turnover Ratio (%)1.281.361.21

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Indoco Remedies Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual736.46623.82613.01
Total Current Assets Annual808.18773.62622.53
Non Current Assets Annual850.02712.47692.54
Total Shareholders Funds Annual1,028.25904.64768.99
Total Assets Annual1,658.21,486.091,315.06

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Indoco Remedies Ltd Earning Calls
Mar 2024
EPS beaten by -2.85 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Indoco Remedies Ltd has a market capitalization of 3,027.14 Cr. Value Research classifies it as a Mid-Cap company.

No, Indoco Remedies Ltd is not debt-free with a debt-to-equity ratio of 0.61.

In FY 2023, Indoco Remedies Ltd recorded a total revenue of approximately 1,788.22 Cr marking a significant milestone in the company's financial performance.

Indoco Remedies Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.1% and 0.1% annually, respectively..

Indoco Remedies Ltd's current PE ratio is 30.74.

Indoco Remedies Ltd's ROCE averaged 15.7% from the FY ending March 2022 to 2024, with a median of 15.9%. It peaked at 21.5% in March 2022, reflecting strong capital efficiency over the period..

Indoco Remedies Ltd's latest EBIT is Rs. 173.82 Cr, surpassing the average EBIT of Rs. 214.12 Cr over the 5 years..